Breast cancer drug
CORNISH breast cancer patients have played an important role in testing a new drug which could extend the lifespan of women who have advanced breast cancer. Royal Cornwall Hospital in Truro was one of just a few centres around the world which carried out studies using the drug Perjeta which has been granted a licence for use today. The drug, developed by Roche, was used in combination with other drugs and treatments in the study which found that patients live for 6.1 months longer without their cancer getting worse. It is for use in patients with untreated and advanced HER2-positive breast cancer and used in combination with the drug Herceptin and chemotherapy. In Cornwall and the Isles of Scilly, 526 women are diagnosed with breast cancer each year. Around 25 per cent of them will be HER2-positive.
Business Cards From Only £10.95 Delivered www.myprint-247.co.uk
View detailsOur heavyweight cards have FREE UV silk coating, FREE next day delivery & VAT included. Choose from 1000's of pre-designed templates or upload your own artwork. Orders dispatched within 24hrs.
Terms: Visit our site for more products: Business Cards, Compliment Slips, Letterheads, Leaflets, Postcards, Posters & much more. All items are free next day delivery. www.myprint-247.co.uk
Contact: 01858 468192
Valid until: Wednesday, May 22 2013
Comments